BELINDA : A phase 3 study evaluating the safety and efficacy of tisagenlecleucel versus standard of care in adult patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

Bishop, Michael and Flinn, Ian and Borchmann, Peter and Jaeger, Ulrich and Westin, Jason and Hamad, Nada and Purtill, Duncan and Greil, Richard and Thomas, Simone and Teshima, Takanori and Harigae, Hideo and Garcia, Carlos and Barba, Pere and Deol, Abhinav and Shaughnessy, Paul and Gu, Jessie and Andreola, Giovanna and Prieto, Marcela Martinez and Pacaud, Lida and Schuster, Stephen (2019) BELINDA : A phase 3 study evaluating the safety and efficacy of tisagenlecleucel versus standard of care in adult patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 7 (Suppl1). ISSN 2051-1426

Full text not available from this repository. (Request a copy)
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Immunologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 23 Mar 2020 09:12
Last Modified: 23 Mar 2020 09:12
URI: https://pred.uni-regensburg.de/id/eprint/25853

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.